HONG KONG – South Korean conglomerate Samsung's biosimilar arm, Samsung Bioepis Co. Ltd., is well under way in expanding its global presence by pushing multiple blockbuster biosimilars into major markets around the world.

HONG KONG – South Korean conglomerate Samsung’s biosimilar arm, Samsung Bioepis Co. Ltd., is well under way in expanding its global presence by pushing multiple blockbuster biosimilars into major markets around the world.